SCHEMBL19988527

SCHEMBL19988527

c1ccc2c(c1)[nH]c1c3oc4ccccc4c3c3cnccc3c21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP3K11 Q16584 2/20 0.52
▸ MAP3K9 P80192 1/20 0.52
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HPGD P15428 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ GMNN O75496 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ NR3C1 P04150 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ CYP1A1 P04798 1/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ LCK P06239 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ CYP3A4 P08684 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ MAPT P10636 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24767896 0.90 KDM4E (0.51) MAP3K11MAP3K9KDM4EALDH1A1HPGD
SCHEMBL17228831 0.87 MAP3K11 (0.59) MAP3K11MAP3K9KDM4EALDH1A1MEN1
SCHEMBL29506369 0.87 MAP3K11 (0.59) MAP3K11MAP3K9KDM4EALDH1A1MEN1
SCHEMBL30883881 0.87 MAP3K11 (0.59) MAP3K11MAP3K9KDM4EALDH1A1MEN1
SCHEMBL21155926 0.80 MAP3K11 (0.43) MAP3K11MAP3K9KDM4EALDH1A1HPGD
SCHEMBL19991873 0.79 MAP3K11 (0.56) MAP3K11MAP3K9ALDH1A1MEN1POLB
SCHEMBL19988566 0.77 MAP3K11 (0.53) MAP3K11MAP3K9KDM4ECDK4CCND1
SCHEMBL19974124 0.77 MAP3K11 (0.53) MAP3K11MAP3K9CDK4CCND1GABRA1
SCHEMBL18086412 0.77 MAP3K11 (0.51) MAP3K11MAP3K9KDM4EALDH1A1MEN1
SCHEMBL17465511 0.77 MAP3K11 (0.51) MAP3K11MAP3K9ALDH1A1MEN1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3512848-B1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2020-11-18 — — EP disclosed
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2019-07-11 — — US disclosed
WO-2018050583-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES MERCK PATENT GMBH (DE) 2018-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214574-A1 COMPOUNDS WITH CARBAZOLE STRUCTURES CYCS, CYP3A4, CYP2E1 MAP3K11 1974/4885MAP3K9 1892/4885KDM4E 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback